Severe hemolytic exacerbations of Chinese PNH patients infected SARS‐CoV‐2 Omicron
Abstract Introduction Paroxysmal nocturnal hemoglobinuria (PNH) is characterized by hemolytic anemia, bone marrow failure, thrombophilia. COVID‐19, caused by a novel severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) with many variants including Omicron. Methods This study collected demogr...
Main Authors: | Hui Yang, Xingxing Chai, Yuemin Gong, Xinyu Zhang, Lingling Wang, Xin Zhou, Xiaoyu Chen, Jinge Xu, Dan Xu, Guangsheng He, Jianyong Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-08-01
|
Series: | Immunity, Inflammation and Disease |
Subjects: | |
Online Access: | https://doi.org/10.1002/iid3.966 |
Similar Items
-
COVID-19 vaccination prevents a more severe course and treatment with complement inhibitors reduce worsening hemolysis during the Omicron pandemic in patients with PNH: a single-center study
by: Leyu Wang, et al.
Published: (2023-12-01) -
Eculizumab treatment: stochastic occurrence of C3 binding to individual PNH erythrocytes
by: Michela Sica, et al.
Published: (2017-06-01) -
Case report: Transfusion independence and abolition of extravascular hemolysis in a PNH patient treated with pegcetacoplan
by: Bruno Fattizzo, et al.
Published: (2022-12-01) -
Presentation and management of paroxysmal nocturnal hemoglobinuria: a single-center experience
by: Mehmet Sinan Dal, et al.
Published: (2016-03-01) -
Novel Insights into Factor D Inhibition
by: Eleni Gavriilaki, et al.
Published: (2022-06-01)